CELG-RI
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$0.11
+0.00%Margins
Gross margin
67.6%
EBITDA margin
34.7%
EBIT margin
32.4%
Net margin
18.9%
FCF margin
23.3%
41.6%
Return on equity
10.6%
Return on assets
23.6%
Return on invested capital
0.56x
Asset turnover
$12.8B
Cash from operations
$5.44
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026